Latest News about Merck & Co Inc

Recent news which mentions Merck & Co Inc

< Previous 1 2 3 4 5 6 7 8 Next >

5 things to know before the stock market opens Wednesday

May 29, 2024

Cramer says these 10 stocks helped the Dow briefly crack 40,000

May 16, 2024

Cramer explains how to maintain a 'balanced' portfolio as the economy slows

May 07, 2024

Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales

April 25, 2024

5 things to know before the stock market opens Monday

April 22, 2024

Cramer’s week ahead: Earnings from Tesla, Merck and Big Tech

April 19, 2024

FDA approves Merck's drug for rare, deadly lung condition

March 26, 2024

Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming

March 19, 2024

Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations

March 13, 2024

Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know

March 10, 2024

New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle

February 23, 2024

Moderna posts surprise quarterly profit even as Covid vaccines sales plummet

February 22, 2024

Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations

February 13, 2024

Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

February 08, 2024

Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch

February 02, 2024

Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales

February 01, 2024

Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat

January 30, 2024

5 things to know before the stock market opens Monday

January 29, 2024

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

January 28, 2024

Cramer's week ahead: Fed meeting, labor report, Big Tech earnings

January 26, 2024

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

January 26, 2024

Dow goes from 37,000 to 38,000 in just 40 days. A history of the Dow and big round numbers

January 23, 2024

Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth

January 14, 2024

J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion

January 08, 2024

Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years

January 02, 2024

Biden administration's Medicare drug price negotiations will face major tests in 2024

December 28, 2023

Jim Cramer explains how FTC chair Lina Khan is hurting investor portfolios

December 18, 2023

Moderna, Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says

December 14, 2023

Pfizer shares fall as 2024 revenue and profit forecast disappoints

December 13, 2023

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

November 30, 2023

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.